摘要
结直肠癌(CRC)是常见的恶性肿瘤之一,手术、放疗、化疗及分子靶向治疗是主要治疗手段。随着近年来免疫学的发展,CRC作为一种免疫源性肿瘤,其免疫治疗亦逐渐引起广泛关注。免疫治疗主要包括单克隆抗体、免疫检查点抑制剂、细胞因子、疫苗等。本文就CRC的免疫治疗的进展进行综述。
Colorectal cancer(CRC) is one of the most common malignant tumors. The surgery, radiotherapy, chemotherapy and molecular targeted therapy are the major treatment of CRC. Due to the development of immunology, as a kind of immunogenicity tumor, CRC can be treated with immunotherapy, which has been widely concerned. In general, the immunotherapies mainly include monoclonal antibody, immune checkpoint inhibitors, cytokines, and vaccine. This review summaries the progress of CRC immunotherapy.
出处
《世界临床药物》
CAS
2017年第11期733-736,740,共5页
World Clinical Drug
基金
上海交通大学医学院高峰高原计划(编号:20172021)
上海市临床技能与临床创新三年行动计划(编号:16CR3038A)
